You just read:

Mallinckrodt Rheumatoid Arthritis Phase 4 Clinical Study for H.P. Acthar® Gel (Repository Corticotropin Injection) Achieves its Enrollment Target

News provided by

Mallinckrodt plc

Jun 28, 2018, 04:45 ET